Stem cell secretion vs hyaluronic acid for knee arthritis
Treatments studied
Part of Bones, joints & muscles clinical trials.
This study compares a new treatment made from stem cell secretions (called secretome) with a standard knee injection (hyaluronic acid) to see which works better for knee osteoarthritis pain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with knee osteoarthritis in one or both knees.
- You are between 40 and 70 years old.
- You have had knee pain for at least 3 months.
- An X-ray shows your knee arthritis is grade 2 or 3 (moderate).
- Your body mass index (BMI) is between 18 and 30.
- You have not had surgery or a major injury to your knee.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a combination of platelet-rich plasma (a concentrate from your own blood) and hyaluronic acid (a joint lubricant) helps reduce pain and improve function in people with knee arthritis. You may be eligible if you have moderate knee pain but your other knee is relatively pain-free.
This study tests whether adding platelet-rich plasma (PRP) to hyaluronic acid injections improves knee osteoarthritis pain and function better than hyaluronic acid alone. You may be eligible if you have moderate knee osteoarthritis and no other knee problems.
This study tests whether an injection of stem cells (special cells that can help repair tissue) works better than a standard hyaluronic acid injection for knee osteoarthritis pain. Both treatments are injected into the knee to reduce pain and improve function.
This trial tests a new treatment using donor stem cells injected into the knee for people with moderate knee osteoarthritis. It aims to see if these cells can reduce pain and improve function.
This study tests whether special stem cells (called UC-MSCs, derived from umbilical cord tissue) can reduce pain and improve function in people with moderate knee osteoarthritis. Researchers will inject these cells into your knee to see if they help repair damaged cartilage and reduce inflammation.
This early-phase study tests whether a special liquid made from stem cells, combined with a protein-rich blood product, can help repair damaged knee cartilage. If you have early osteoarthritis, this might reduce pain and improve knee function.
Hear when a new Knee Osteoarthritis (Knee OA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.